All posts by: Michael Zand

About Michael Zand

VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit – Marketwired (press release)

Continue reading

2017-08-28 NEWS

VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit
Marketwired (press release)
VBI-1901 is a novel immunotherapy developed using VBI’s eVLP technology to target CMV-positive (CMV+) tumors, including glioblastoma multiforme (GBM), the company’s lead immuno-oncology program. Dr. Anderson will present data in animal models …

and more »

Continue reading

2017-08-28 NEWS

Markets Insider

Gilead just bought a cancer-immunotherapy company for $12 billion
Markets Insider
Gilead, known for its HIV and hepatitis C drugs, has been growing a cash pile over the past few years since the approval of its hepatitis C drug in 2013, leading investors to speculate what company it might buy. Gilead’s purchase of Kite is the first
Kite Soars on Sale to Gilead – Biotech MoversTheStreet.com
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell TherapyXconomy
Gilead is buying Santa Monica biotech firm Kite Pharma for $11.9 billionLos Angeles Times
STLtoday.com –Proactive Investors UK
all 162 news articles »
Continue reading

2017-08-28 NEWS

STAT

Gilead agrees to buy Kite Pharma, leaping into CART cancer therapy
STAT
With the Kite deal, Gilead becomes a player in a new type of blockbuster cancer treatment in which a patient’s own immune cells are re-engineered to recognize and kill cancer cells — a technology known as CART. Kite’s lead therapy, known as axi-cel, …
Gilead to Buy Kite for Promising Cancer Therapies in $12 Billion DealNew York Times
Gilead to buy Kite Pharma for about $12 billionSTLtoday.com
Gilead Sciences to Acquire Israeli Cancer Curing Kite Pharma for $11.9 BillionThe Jewish Press – JewishPress.com
Modesto Bee
all 114 news articles »
Continue reading

2017-08-28 NEWS

BBC News

TEDGlobal: The computer that can smell explosives
BBC News
“We think that the processing power that is going to run the robots of the future will be synthetic biology-based and we are laying the foundations for that today.” The fusion of biology and technology gained headlines recently when Elon Musk, chief
Computer of Future which will smell explosives like dogs—TED GlobalRS-Tech (press release) (blog)

all 5 news articles »